We are live on !
Find out more
Sovran Advisors Portfolio holdings
AUM
$1.45B
Turnover
15.93%
1-Year Est. Return
13.87%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+13.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.13B
AUM Growth
+$177M
(+19%)
Cap. Flow
+$99.2M
Cap. Flow % of AUM
Cap. Flow %
8.76%
Top 10 Holdings %
Top 10 Hldgs %
19.04%
Holding
555
New
69
Increased
253
Reduced
186
Closed
36
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BitMine Immersion Technologies
BMNR
|
+$8.11M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$4.63M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$4.57M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$4M |
| 5 |
Apple
AAPL
|
+$3.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$8.35M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$4.14M |
| 3 |
Summit Therapeutics
SMMT
|
+$3.45M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.41M |
| 5 |
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.99% |
| 2 | Technology | 10.61% |
| 3 | Healthcare | 3.62% |
| 4 | Financials | 3.32% |
| 5 | Consumer Discretionary | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares Core S&P 500 ETF
IVV
$847B
| $30M | 2.65% |
43,867
+2,854
| +7% | +$1.84M |
2024 Q4
3 quarters
|
|
|
2
Apple
AAPL
$4.98T
| $27.6M | 2.44% |
101,559
+17,335
| +21% | +$3.92M |
2024 Q4
3 quarters
|
|
3
NVIDIA
NVDA
$4.51T
| $24.3M | 2.15% |
119,865
+12,620
| +12% | +$2.2M |
2024 Q4
3 quarters
|
|
4
Innovator US Equity Ultra Buffer ETF September
USEP
$240M
| $24.2M | 2.14% |
621,789
+20,722
| +3% | +$783K |
2024 Q4
3 quarters
|
|
5
Microsoft
MSFT
$3.94T
| $21.6M | 1.91% |
41,033
+1,202
| +3% | +$613K |
2024 Q4
3 quarters
|
|
|
6
iShares Bitcoin Trust
IBIT
$61.7B
| $19.6M | 1.73% |
323,741
+70,329
| +28% | +$4.57M |
2024 Q4
3 quarters
|
|
|
7
BlackRock US Equity Factor Rotation ETF
DYNF
$40.3B
| $18.9M | 1.67% |
311,229
+81,589
| +36% | +$4.63M |
2024 Q4
3 quarters
|
|
8
iShares MSCI USA Quality Factor ETF
QUAL
$11.8B
| $17.1M | 1.51% |
347,220
+40,364
| +13% | +$1.89M |
2024 Q4
3 quarters
|
|
9
iShares S&P 500 Value ETF
IVE
$49.9B
| $16.3M | 1.44% |
78,275
+17,668
| +29% | +$3.55M |
2024 Q4
3 quarters
|
|
10
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $16M | 1.41% |
23,498
+467
| +2% | +$299K |
2024 Q4
3 quarters
|
|
11
Capital Group Dividend Value ETF
CGDV
$37.8B
| $15.6M | 1.38% |
366,757
+67,327
| +22% | +$2.77M |
2024 Q4
3 quarters
|
|
12
iShares S&P 500 Growth ETF
IVW
$72.1B
| $15.2M | 1.35% |
122,395
+10,177
| +9% | +$1.17M |
2024 Q4
3 quarters
|
|
13
iShares Core Universal USD Bond ETF
IUSB
$50.2B
| $13.4M | 1.18% |
285,038
-66,481
| -19% | -$3.07M |
2024 Q4
3 quarters
|
|
14
Capital Group Core Plus Income ETF
CGCP
$8.65B
| $12.9M | 1.14% |
563,992
+101,482
| +22% | +$2.29M |
2024 Q4
3 quarters
|
|
15
Amazon
AMZN
$2.8T
| $11.7M | 1.04% |
52,627
+11,226
| +27% | +$2.54M |
2024 Q4
3 quarters
|
|
16
iShares MSCI EAFE Value ETF
EFV
$15.1B
| $11.6M | 1.03% |
339,216
-30,144
| -8% | -$993K |
2024 Q4
3 quarters
|
|
17
Capital Group Growth ETF
CGGR
$24.9B
| $11.4M | 1.01% |
256,691
-22,051
| -8% | -$931K |
2024 Q4
3 quarters
|
|
|
18
Ionis Pharmaceuticals
IONS
$6.55B
| $11.2M | 0.99% |
150,856
-171,057
| -53% | -$8.35M |
2024 Q4
3 quarters
|
|
19
Vanguard S&P 500 ETF
VOO
$996B
| $10.6M | 0.94% |
16,965
+1,734
| +11% | +$1.02M |
2024 Q4
3 quarters
|
|
20
iShares 20+ Year Treasury Bond ETF
TLT
$47.7B
| $10.5M | 0.93% |
115,900
+7,272
| +7% | +$636K |
2024 Q4
3 quarters
|
|
21
Invesco QQQ Trust
QQQ
$443B
| $10.5M | 0.92% |
16,692
-424
| -2% | -$243K |
2024 Q4
3 quarters
|
|
22
Innovator Equity Defined Protection ETF - 1 Yr July
ZJUL
$191M
| $10.4M | 0.92% |
361,973
+28,064
| +8% | +$799K |
2025 Q2
1 quarter
|
|
23
SPDR Gold Trust
GLD
$136B
| $10M | 0.88% |
27,053
-6,171
| -19% | -$1.97M |
2024 Q4
3 quarters
|
|
|
24
iShares S&P 100 ETF
OEF
$19.5B
| $9.8M | 0.87% |
28,472
+12,593
| +79% | +$4M |
2024 Q4
3 quarters
|
|
25
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $9.5M | 0.84% |
188,068
-26,716
| -12% | -$1.35M |
2024 Q4
3 quarters
|
|
Similar funds
SS
Sovran Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Sovran Advisors held 555 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Sovran Advisors deployed $99.2M of net new capital in Q3 2025, opening 69 new positions and adding to 253 existing holdings. Its largest new stake was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $8.35M trimmed.
- Sovran Advisors's largest Q3 2025 buy was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
- Sovran Advisors added most to BlackRock US Equity Factor Rotation ETF in Q3 2025, an estimated $4.63M increase.
- Sovran Advisors's biggest Q3 2025 reduction was Ionis Pharmaceuticals, cutting an estimated $8.35M.
- Sovran Advisors fully exited Summit Therapeutics in Q3 2025, selling an estimated $3.45M.
- Sovran Advisors's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
- Sovran Advisors opened 69 new positions and closed 36 in Q3 2025.
- Sovran Advisors's portfolio value rose 19% quarter-over-quarter to $1.13B.
Based on Sovran Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.